When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Orlistat - Wikipedia

   en.wikipedia.org/wiki/Orlistat

   Orlistat, sold under the brand name Xenical among others, is a medication used to treat obesity. Its primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby reducing caloric intake. It is intended for use in conjunction with a healthcare provider-supervised reduced-calorie diet.

3. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   e. Orlistat (Xenical), the most commonly used medication to treat obesity and sibutramine (Meridia), a medication that was withdrawn due to cardiovascular side effects. Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control excess body fat. These medications alter one of the fundamental processes of ...

4. Which Medications Are FDA-Approved for Weight Loss? - AOL

   www.aol.com/medications-fda-approved-weight-loss...

   Qsymia (Phentermine-Topiramate) Qsymia is a once-daily oral weight loss medication approved for adults and adolescents 12 years and older who meet the BMI criteria. This medicine works on ...

5. Phentermine - Wikipedia

   en.wikipedia.org/wiki/Phentermine

   Phentermine (phenyl-tertiary-butyl amine), sold under the brand name Ionamin among others, is a medication used together with diet and exercise to treat obesity. [3] It is taken by mouth for up to a few weeks at a time, after which the benefits subside. [3]

6. Weight loss drugs like Wegovy may trigger eating ... - AOL

   www.aol.com/news/weight-loss-drugs-wegovy-may...

   Updated August 1, 2024 at 7:21 AM. Over the past six months, psychologist Tom Hildebrandt has seen an increase in patients with eating disorders who are taking popular weight loss drugs like ...

7. Phentermine/topiramate - Wikipedia

   en.wikipedia.org/wiki/Phentermine/topiramate

   In clinical trials, the most common adverse events which occurred at a rate ≥5% and ≥1.5 times placebo included paraesthesia (tingling in fingers/toes), dizziness, altered taste, insomnia, constipation, and dry mouth.